Garid, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Garid, Inc. makes
Garid, Inc. manufactures medical devices for blood glucose monitoring, including the NOVOCHECK/CHECKPOINT/CONTROL SOLUTION for continuous glucose tracking and the MED-PEN/MED-POINT for insulin delivery systems.
These devices are classified as Class II under FDA regulations and are listed via the 510(k) pathway. The company is based in the United States.
Catalogue
Novocheck/Checkpoint/Control Solution Ref K872049
Regimes: 510(k) Registry: 510(k)Med-Pen/Med-Point Ref K853733
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Garid, Inc. have in the registry?
The registry currently lists 2 devices for Garid, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Garid, Inc.'s devices?
Among its 2 most recently registered devices, Garid, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Garid, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Garid, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Garid, Inc. in the registry?
The most recently registered devices listed for Garid, Inc. include NOVOCHECK/CHECKPOINT/CONTROL SOLUTION and MED-PEN/MED-POINT.